Novel Treatment for Rotator Cuff Tears
Ultrasonic Tenotomy as a Treatment of Partial Rotator Cuff Tear of the Supraspinatus Tendon: A Pilot Feasibility Study
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Wisconsin
-
Onalaska, Wisconsin, United States, 54650
- Recruiting
- Mayo Clinic Health System - Onalaska
-
Contact:
- Jacob Erickson, DO
- Phone Number: 608-392-9876
- Email: erickson.jacob@mayo.edu
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Evidence of partial tear (< 50%) of the supraspinatus tendon on MRI.
Exclusion Criteria:
- A tear of the supraspinatus tendon greater > 50% and any areas of full thickness tearing, concomitant tears > 25% of other rotator cuff tendons (infraspinatus, teres minor or subscapularis), or acute tear of the glenoid labrum.
- Evidence of systemic illness/infection requiring oral or IV antibiotics during the recruitment period.
- Evidence of overlying skin infection or lesion at the proposed device insertion point on the shoulder.
- Previous corticosteroid injection within three months.
- Those individuals less than 25 and greater than 75 years of age will be excluded.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Other: Repair a partially torn rotator cuff
Subjects will undergo an ultrasonic tenotomy to repair a partially torn rotator cuff per standard of care as clinically indicated
|
Ultrasonic procedure as part of standard of care, as clinically indicated, to stimulate healing of the partial tear.
The procedure uses ultrasound guidance that allows a needlelike device to gradually break up and remove tendinopathic tendon tissue.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in pain
Time Frame: Baseline, 2, 6, 12 and 24-weeks post-procedure
|
Measured using a visual analog scale (VAS), used to measure subjective pain, rated from 0 (no pain) to 100 (most severe pain) at rest and during activity (previously painful activities)
|
Baseline, 2, 6, 12 and 24-weeks post-procedure
|
|
Change in shoulder active range of motion
Time Frame: Baseline, 2, 6, 12 and 24-weeks post-procedure
|
Measured using a goniometer reported in degrees
|
Baseline, 2, 6, 12 and 24-weeks post-procedure
|
|
Change in shoulder strength
Time Frame: Baseline, 2, 6, 12 and 24-weeks post-procedure
|
Assessed using a hand-held dynamometer (HHD) placed distally on the forearm, just proximal to the wrist joint along the distal radius and ulna with instruction to push into the HHD with maximum force production for approximately 5 seconds.
|
Baseline, 2, 6, 12 and 24-weeks post-procedure
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in quality of life
Time Frame: Baseline, 2, 6, 12 and 24-weeks post-procedure
|
Measured using the SF-36 Quality of Life questionnaire which is a 36-item self-reported health survey that measures health and disability.
Possible scores range from 0 to 100, with 0 indicating maximum disability, and 100 indicating no disability.
|
Baseline, 2, 6, 12 and 24-weeks post-procedure
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Jacob Erickson, DO, Mayo Clinic
Publications and helpful links
Helpful Links
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 21-011522
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.